Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Accumulated Expenses (2019 - 2025)

Legend Biotech filings provide 7 years of Other Accumulated Expenses readings, the most recent being $1.0 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 100.0% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 100.0% increase, with the full-year FY2025 number at $1.0 million, up 100.0% from a year prior.
  • Other Accumulated Expenses hit $1.0 million in Q4 2025 for Legend Biotech, down from $1.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $184.1 million in Q4 2022 to a low of $80096.0 in Q1 2021.
  • Median Other Accumulated Expenses over the past 5 years was $119.6 million (2023), compared with a mean of $90.9 million.
  • Biggest five-year swings in Other Accumulated Expenses: soared 128705.84% in 2021 and later crashed 99.59% in 2024.
  • Legend Biotech's Other Accumulated Expenses stood at $123.6 million in 2021, then skyrocketed by 49.01% to $184.1 million in 2022, then plummeted by 33.57% to $122.3 million in 2023, then crashed by 99.59% to $500000.0 in 2024, then skyrocketed by 100.0% to $1.0 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $1.0 million (Q4 2025), $1.3 million (Q3 2025), and $138.8 million (Q2 2025) per Business Quant data.